News

Gilead acquires Phenex program for NASH and other liver diseases

Gilead acquires Phenex program for NASH and other liver diseases

06-01-2015

US biotech major Gilead Sciences and privately-held German biotech firm Phenex Pharmaceuticals have signed…

AvogenxBiotechnologyGilead SciencesIntercept PharmaceuticalsMergers & AcquisitionsNephrology and HepatologyPhenex Pharmaceuticals

France negotiates lowest price in Europe for Gilead’s Sovaldi

France negotiates lowest price in Europe for Gilead’s Sovaldi

21-11-2014

The discount negotiated by the French government on hepatitis C drug Sovaldi (sofosbuvir), produced by…

FranceGilead SciencesNephrology and HepatologyPharmaceuticalPoliticsPricingRegulationSovaldi

COMPANY SPOTLIGHT

Menarini

Back to top